Megumi Ichikawa
- Biomedical Engineering top 10%
- Pulmonary and Respiratory Medicine top 10%
- Molecular Biology
- Materials Chemistry
- Biotechnology top 10%
- Co-authors
- Sriram AnbilGirgis ObaidAnne‐Laure BulinTayyaba HasanSrivalleesha MallidiJiro AkimotoMichihiro KohnoShinjiro Fukami
- Topics
- Nanoplatforms for cancer theranostics (7 papers)Photodynamic Therapy Research Studies (6 papers)Glycosylation and Glycoproteins Research (5 papers)
In The Last Decade
Megumi Ichikawa
27 papers receiving 680 citations
Hit Papers
Peers
Comparison fields: 5 of 91
- Biomedical Engineering 364
- Pulmonary and Respiratory Medicine 274
- Molecular Biology 170
- Materials Chemistry 147
- Biotechnology 68
Countries citing papers authored by Megumi Ichikawa
This map shows the geographic impact of Megumi Ichikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Megumi Ichikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Megumi Ichikawa more than expected).
Fields of papers citing papers by Megumi Ichikawa
This network shows the impact of papers produced by Megumi Ichikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Megumi Ichikawa. The network helps show where Megumi Ichikawa may publish in the future.
Co-authorship network of co-authors of Megumi Ichikawa
This figure shows the co-authorship network connecting the top 25 collaborators of Megumi Ichikawa. A scholar is included among the top collaborators of Megumi Ichikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Megumi Ichikawa. Megumi Ichikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 4 | |
| 3 | 2 | |
| 4 | 4 | |
| 5 | 4 | |
| 6 | 17 | |
| 7 | 33 | |
| 8 | 14 | |
| 9 | 10 | |
| 10 | Beyond the Barriers of Light Penetration: Strategies, Perspectives and Possibilities for Photodynamic Therapybreakdown → | 338 |
| 11 | 25 | |
| 12 | 8 | |
| 13 | 3 | |
| 14 | 7 | |
| 15 | 30 | |
| 16 | 2 | |
| 17 | 18 | |
| 18 | 32 | |
| 19 | 37 | |
| 20 | Ovarian function after bone marrow transplantation before menarche | 1 |
About Megumi Ichikawa
Megumi Ichikawa is a scholar working on Biotechnology, Ophthalmology and Endocrinology, Diabetes and Metabolism, having authored 27 papers that have together received 689 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (7 papers), Photodynamic Therapy Research Studies (6 papers) and Glycosylation and Glycoproteins Research (5 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (274 citations), Biomedical Engineering (364 citations) and Biotechnology (68 citations). Megumi Ichikawa has collaborated with scholars based in Japan, Cambodia and Egypt. Frequent co-authors include Sriram Anbil, Girgis Obaid, Anne‐Laure Bulin, Tayyaba Hasan, Srivalleesha Mallidi, Jiro Akimoto, Michihiro Kohno, Shinjiro Fukami, Takatsugu Miyazaki and Atsushi Nishikawa. Their work appears in journals such as PLANT PHYSIOLOGY, Scientific Reports and Biochemical Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.